Mirum Pharmaceuticals, Inc. (MIRM) [Rocket]

In millions, except per share items	Jun-30-23	Mar-31-23	Dec-31-22	Sep-30-22	Jun-30-22	Dec-31-21	Sep-30-21	Jun-30-21
	10-Q	10-Q	8-K	10-Q	10-Q	10-K	10-Q	10-Q
Assets
Cash and equivalents	297.2	49.4		35.8	55.3	31.3	55.8	91.9
Short-term investments	32.7	82.7		149.6	69.7	125.2	134.2	131.9
Accounts receivable, net	35.3	24.7		16.3	14.0	3.3
Inventories						1.5
Other current assets	18.2	15.6		13.9	8.3	5.3	6.8	4.5
Total current assets	383.5	172.3		215.6	147.2	166.6	196.8	228.4
Property, plant, and equipment, net	0.9	0.9		0.8	0.8	1.0	1.1	1.1
Intangibles	56.4	57.7		45.0	46.1	18.7	19.0
Long-term investments						10.0	15.0	15.0
Other fixed assets	1.2	1.3		1.7	1.7	1.8	1.6	1.4
Total assets	443.6	333.5		364.3	297.2	294.7	235.2	247.7

Accounts payable	14.4	6.4		10.5	8.1	9.2	5.0	5.4
Accrued expenses	17.5	16.5		15.9	11.9	30.7	11.2	8.0
Short-term debt	0.0	0.0		0.0	0.0	0.0	0.0	0.0
Other current liabilities	26.2	25.9		24.9	25.2	2.7	34.2	15.7
Total current liabilities	58.2	48.8		51.4	45.2	42.6	50.4	29.0
Long-term debt	305.6
Other liabilities	1.2	143.5		143.7	141.4	131.8	128.4	122.9
Total liabilities	365.0	192.4		195.1	186.5	174.4	178.8	151.9

Shareholders' equity [+]	78.6	141.2		169.3	110.7	120.2	56.4	95.7
Paid-in capital	575.5	564.0		526.1	431.6	377.4	371.1	363.3
Retained earnings	-497.0	-423.0		-356.4	-320.7	-257.2	-314.7	-267.6
Tangible shareholders' equity	22.2	83.5		124.3	64.6	101.5	37.4	95.7